Michael J Rybak (Taylor Morrisette)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 25

Top Venues

Infectious diseases and therapy

Open forum infectious diseases

Antimicrobial agents and chemotherapy

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Michael J Rybak, Shahad Alghamdi, Megan B Maree, Terry C Dixon, Stephen A Thacker
One and Done? An Evaluation of the Clinical Outcomes of Single- and Multi-Dose Dalbavancin Use in the Pediatric Population. Journal of pharmacy practice (2024)
Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T Anderson, Monica V Mahoney, Wesley D Kufel, Joseph A D'Antonio, Bruce M Jones, Jeremy J Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P Veve, Michael J Rybak
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study. Infectious diseases and therapy 13 (3) (2024)
Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T Anderson, Monica V Mahoney, Wesley D Kufel, Joseph A D'Antonio, Bruce M Jones, Jeremy J Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P Veve, Michael J Rybak
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study. Infectious diseases and therapy 13 (3) (2024)
Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T Anderson, Monica V Mahoney, Wesley D Kufel, Joseph A D'Antonio, Bruce M Jones, Jeremy J Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P Veve, Michael J Rybak
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study. Infectious diseases and therapy 13 (3) (2024)
Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T Anderson, Monica V Mahoney, Wesley D Kufel, Joseph A D'Antonio, Bruce M Jones, Jeremy J Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P Veve, Michael J Rybak
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study. Infectious diseases and therapy (2024)
Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T Anderson, Monica V Mahoney, Wesley D Kufel, Joseph A D'Antonio, Bruce M Jones, Jeremy J Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P Veve, Michael J Rybak
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study. Infectious diseases and therapy 13 (3) (2024)
Nicholas Rebold, Sara Alosaimy, Jeffrey C Pearson, Brandon Dionne, Ahmad Taqi, Abdalhamid Lagnf, Kristen Lucas, Mark Biagi, Nicholas Lombardo, Joshua Eudy, Daniel T Anderson, Monica V Mahoney, Wesley D Kufel, Joseph A D'Antonio, Bruce M Jones, Jeremy J Frens, Tyler Baumeister, Matthew Geriak, George Sakoulas, Dimitrios Farmakiotis, Dino Delaportas, Jeremy Larew, Michael P Veve, Michael J Rybak
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study. Infectious diseases and therapy 13 (3) (2024)
Michael J Rybak, Kyle C Stamper, Katherine L Lev, Razieh Kebriaei, Dana J Holger, Jacinda C Abdul-Mutakabbir, Ashlan J Kunz Coyne, Michael Joseph Rybak
Evaluation of Omadacycline Alone and in Combination with Rifampin against Staphylococcus aureus and Staphylococcus epidermidis in an In Vitro Pharmacokinetic/Pharmacodynamic Biofilm Model. Antimicrobial agents and chemotherapy (2023)
Razieh Kebriaei, Jacinda C Abdul-Mutakabbir, Kyle C Stamper, Katherine L Lev, Michael J Rybak
Targeting Dalbavancin Inoculum Effect: Adjunctive Single Dose of Daptomycin. Infectious diseases and therapy (2023)
Razieh Kebriaei, Katherine L Lev, Rahi M Shah, Kyle C Stamper, Dana J Holger, Michael J Rybak, Ashlan J Kunz Coyne, Susan M Lehman, Michael Joseph Rybak
Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro : Bacteriophage-Antibiotic Combination. Microbiology spectrum 10 (2) (2022)
Michael J Rybak, Kyle C Molina, Beatriz Da Silva, Scott W Mueller, Laura Damioli, Martin Kršák, Matthew A Miller, Douglas N Fish
Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success. Open forum infectious diseases 9 (6) (2022)
Ashlan J Kunz Coyne, Amer El Ghali, Dana J Holger, Nicholas Rebold, Michael J Rybak
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infectious diseases and therapy 11 (2) (2022)
Katherine Lev, Ashlan J Kunz Coyne, Razieh Kebriaei, Michael J Rybak, Kyle Stamper, Dana J Holger, Gregory S Canfield, Breck A Duerkop, Cesar A Arias, Michael Joseph Rybak
Evaluation of Bacteriophage-Antibiotic Combination Therapy for Biofilm-Embedded MDR Enterococcus faecium . Antibiotics (Basel, Switzerland) 11 (3) (2022)
E J Zasowski, T D Trinh, K C Claeys, M Dryden, S Shlyapnikov, M Bassetti, A Carnelutti, N Khachatryan, A Kurup, Abraham Pulido Cejudo, L Melo, B Cao, Michael J Rybak
International Validation of a Methicillin-Resistant Staphylococcus aureus Risk Assessment Tool for Skin and Soft Tissue Infections. Infectious diseases and therapy 11 (6) (2022)
Dana J Holger, Nicholas S Rebold, Sara Alosaimy, Taylor Morrisette, Abdalhamid Lagnf, Ana Christine Belza, Ashlan J Kunz Coyne, Amer El Ghali, Michael P Veve, Michael J Rybak
Impact of Ceftolozane-Tazobactam vs. Best Alternative Therapy on Clinical Outcomes in Patients with Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Lower Respiratory Tract Infections. Infectious diseases and therapy 11 (5) (2022)
Taylor Morrisette, Sara Alosaimy, Abdalhamid M Lagnf, Jeremy J Frens, Andrew J Webb, Michael P Veve, Ryan Stevens, Jeannette Bouchard, Tristan W Gore, Iman Ansari, Michael J Rybak
Real-World, Multicenter Case Series of Patients Treated with Oral Omadacycline for Resistant Gram-Negative Pathogens. Infectious diseases and therapy 11 (4) (2022)
Kelli A Cole, Anna Y Zhou, Travis Jones, W Justin Moore, Elisabeth L Chandler, Veronica B Zafonte, Michael J Rybak, Timothy P Gauthier, Jamie Kisgen, Amanda Barner, Melissa D Johnson, R Dawn Tagare, Julie Ann Justo
How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 74 (Suppl_3) (2022)
Nicholas Rebold, Sara Alosaimy, Taylor Morrisette, Dana Holger, Abdalhamid M Lagnf, Iman Ansari, Ana C Belza, Laura Cheaney, Huzaifa Hussain, Shelbye R Herbin, Jacinda Abdul-Mutakabbir, Caitlin Carron, Avnish Sandhu, Teena Chopra, Michael J Rybak
Clinical Characteristics Associated with Bacterial Bloodstream Coinfection in COVID-19. Infectious diseases and therapy 11 (3) (2022)
Nicholas Rebold, Michael J Rybak, Abdalhamid M Lagnf, Sara Alosaimy, Dana Holger, Katie E Barber, Julie Ann Justo, Kayla Antosz, Travis J Carlson, Jeremy J Frens, Mark J Biagi, Wesley D Kufel, William J Moore, Nicholas J Mercuro, Brian R Raux, Michael Joseph Rybak
Early Multicenter Experience With Imipenem-Cilastatin-Relebactam for Multidrug-Resistant Gram-Negative Infections. Open forum infectious diseases 8 (12) (2021)
Michael J Rybak, Abdalhamid M Lagnf, Sara Alosaimy, Michael J Rybak
A comparison of daptomycin alone and in combination with ceftaroline fosamil for methicillin-resistant Staphylococcus aureus bacteremia complicated by septic pulmonary emboli. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 39 (11) (2020)
Michael J Rybak, Razieh Kebriaei, Katherine L Lev, Sandra Morales, Michael Joseph Rybak
Bacteriophage Therapeutics: A Primer for Clinicians on Phage-Antibiotic Combinations. Pharmacotherapy 40 (2) (2020)
Taylor Morrisette, Thomas P Lodise, Marc H Scheetz, Srijib Goswami, Jason M Pogue, Michael J Rybak
The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the Horse. Infectious diseases and therapy 9 (3) (2020)
Kyle C Molina, Michael J Rybak, Matthew A Miller, Vanthida Huang, Douglas N Fish
The Emerging Role of β-Lactams in the Treatment of Methicillin-Resistant Staphylococcus aureus Bloodstream Infections. Antimicrobial agents and chemotherapy 64 (7) (2020)
Michael J Rybak, Katherine L Lev, Razieh Kebriaei, Jacinda C Abdul-Mutakabbir, Kyle C Stamper, Sandra Morales, Susan M Lehman, Gregory S Canfield, Breck A Duerkop, Cesar A Arias, Michael Joseph Rybak
Bacteriophage-Antibiotic Combinations for Enterococcus faecium with Varying Bacteriophage and Daptomycin Susceptibilities. Antimicrobial agents and chemotherapy 64 (9) (2020)
Michael J Rybak, Matthew A Miller, Brian T Montague, Gerard R Barber, R Brett McQueen, Martin Kršák
Long-Acting Lipoglycopeptides: "Lineless Antibiotics" for Serious Infections in Persons Who Use Drugs. Open forum infectious diseases 6 (7) (2019)

Michael J Rybak.css-eqlu8i{font-size:small;padding-left:4px;} (Taylor Morrisette)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael J Rybak (Taylor Morrisette)